As healthcare costs increase and specialty medications proliferate, health plans and other payers increasingly use cost-containment tools to control access through drug utilization management. Unfortunately, some tools, specifically prior authorization, create administrative hurdles that may keep patients away from – or adhering to – the therapy their healthcare providers prescribe.

In this white paper, learn:

• What's next in drug utilization management for specialty and specialty-lite drugs
  
• How to manage the burden of $93B in annual costs due to UM
  
• Why life sciences brands need a PA strategy
  
• How to build an effective and efficient PA approach